Lilia Cantero Aguilar

Myotonic dystrophy kinase‐related CDC42‐binding kinase α, a new transferrin receptor type 2‐binding partner, is a regulator of erythropoiesis

C. Richard, F. Verdier, P. Mayeux, 2021, American journal of hematology.

Pairing MCL‐1 inhibition with venetoclax improves therapeutic efficiency of BH3‐mimetics in AML

J. Tamburini, F. Guillonneau, M. Fontenay, 2020, European journal of haematology.